These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 9133505)
21. Effects of protein A immunoadsorption in patients with advanced chronic dilated cardiomyopathy. Doesch AO; Konstandin M; Celik S; Kristen A; Frankenstein L; Hardt S; Goeser S; Kaya Z; Katus HA; Dengler TJ J Clin Apher; 2009; 24(4):141-9. PubMed ID: 19591221 [TBL] [Abstract][Full Text] [Related]
22. Myocardial gene expression profiles and cardiodepressant autoantibodies predict response of patients with dilated cardiomyopathy to immunoadsorption therapy. Ameling S; Herda LR; Hammer E; Steil L; Teumer A; Trimpert C; Dörr M; Kroemer HK; Klingel K; Kandolf R; Völker U; Felix SB Eur Heart J; 2013 Mar; 34(9):666-75. PubMed ID: 23100283 [TBL] [Abstract][Full Text] [Related]
23. The effect of a repeated immunoadsorption in patients with dilated cardiomyopathy after recurrence of severe heart failure symptoms. Reinthaler M; Empen K; Herda LR; Schwabe A; Rühl M; Dörr M; Felix SB J Clin Apher; 2015 Aug; 30(4):217-23. PubMed ID: 25346275 [TBL] [Abstract][Full Text] [Related]
24. Effects of immunoadsorption and subsequent immunoglobulin G substitution on cardiopulmonary exercise capacity in patients with dilated cardiomyopathy. Herda LR; Trimpert C; Nauke U; Landsberger M; Hummel A; Beug D; Kieback A; Dörr M; Empen K; Knebel F; Ewert R; Angelow A; Hoffmann W; Felix SB; Staudt A Am Heart J; 2010 May; 159(5):809-16. PubMed ID: 20435190 [TBL] [Abstract][Full Text] [Related]
25. Immunoadsorption in dilated cardiomyopathy: 6-month results from a randomized study. Staudt A; Hummel A; Ruppert J; Dörr M; Trimpert C; Birkenmeier K; Krieg T; Staudt Y; Felix SB Am Heart J; 2006 Oct; 152(4):712.e1-6. PubMed ID: 16996843 [TBL] [Abstract][Full Text] [Related]
26. Therapeutic effect of immunoadsorption and subsequent immunoglobulin substitution in patients with dilated cardiomyopathy: Results from the observational prospective Bad Berka Registry. Ohlow MA; Brunelli M; Schreiber M; Lauer B J Cardiol; 2017 Feb; 69(2):409-416. PubMed ID: 27890513 [TBL] [Abstract][Full Text] [Related]
27. Role of β₁-adrenoceptor autoantibodies in the pathogenesis of dilated cardiomyopathy. Dandel M; Wallukat G; Potapov E; Hetzer R Immunobiology; 2012 May; 217(5):511-20. PubMed ID: 21820755 [TBL] [Abstract][Full Text] [Related]
28. Autoantibodies in dilated cardiomyopathy induce vascular endothelial growth factor expression in cardiomyocytes. Saygili E; Noor-Ebad F; Schröder JW; Mischke K; Saygili E; Rackauskas G; Marx N; Kelm M; Rana OR Biochem Biophys Res Commun; 2015 Sep; 465(1):119-24. PubMed ID: 26248134 [TBL] [Abstract][Full Text] [Related]
29. Stimulating autoantibodies directed against the cardiac beta1-adrenergic receptor predict increased mortality in idiopathic cardiomyopathy. Störk S; Boivin V; Horf R; Hein L; Lohse MJ; Angermann CE; Jahns R Am Heart J; 2006 Oct; 152(4):697-704. PubMed ID: 16996841 [TBL] [Abstract][Full Text] [Related]
30. Immunoadsorption in patients with dilated cardiomyopathy. Herda LR; Felix SB; Staudt A Atheroscler Suppl; 2009 Dec; 10(5):126-8. PubMed ID: 20129390 [TBL] [Abstract][Full Text] [Related]
31. Autoantigen estimation and simple screening assay against cardiodepressant autoantibodies in patients with dilated cardiomyopathy. Baba A Ther Apher Dial; 2008 Apr; 12(2):109-16. PubMed ID: 18387158 [TBL] [Abstract][Full Text] [Related]
32. Immunoadsorption in dilated cardiomyopathy: long-term reduction of cardiodepressant antibodies. Trimpert C; Herda LR; Eckerle LG; Pohle S; Müller C; Landsberger M; Felix SB; Staudt A Eur J Clin Invest; 2010 Aug; 40(8):685-91. PubMed ID: 20546018 [TBL] [Abstract][Full Text] [Related]
33. Immunoadsorption therapy for dilated cardiomyopathy using tryptophan column-A prospective, multicenter, randomized, within-patient and parallel-group comparative study to evaluate efficacy and safety. Yoshikawa T; Baba A; Akaishi M; Wakabayashi Y; Monkawa T; Kitakaze M; Izumi T; Tomoike H J Clin Apher; 2016 Dec; 31(6):535-544. PubMed ID: 26801483 [TBL] [Abstract][Full Text] [Related]
34. Reduction of morbidity by immunoadsorption therapy in patients with dilated cardiomyopathy. Knebel F; Böhm M; Staudt A; Borges AC; Tepper M; Jochmann N; Wernicke KD; Felix S; Baumann G Int J Cardiol; 2004 Dec; 97(3):517-20. PubMed ID: 15561342 [TBL] [Abstract][Full Text] [Related]
35. Beta 1-adrenergic receptor-directed autoimmunity as a cause of dilated cardiomyopathy in rats. Jahns R; Boivin V; Lohse MJ Int J Cardiol; 2006 Sep; 112(1):7-14. PubMed ID: 16872696 [TBL] [Abstract][Full Text] [Related]
36. [The role of anti-beta1-adrenergic receptor autoantibodies in development of heart failure]. Tonevitskiĭ AG; Tabak'an EA Ross Fiziol Zh Im I M Sechenova; 2006 Mar; 92(3):330-41. PubMed ID: 16739643 [TBL] [Abstract][Full Text] [Related]
37. Immunoadsorption and subsequent immunoglobulin substitution decreases myocardial gene expression of desmin in dilated cardiomyopathy. Kallwellis-Opara A; Staudt A; Trimpert C; Noutsias M; Kühl U; Pauschinger M; Schultheiss HP; Grube M; Böhm M; Baumann G; Völker U; Kroemer HK; Felix SB J Mol Med (Berl); 2007 Dec; 85(12):1429-35. PubMed ID: 17924085 [TBL] [Abstract][Full Text] [Related]
38. Improvement of cardiac function after immunoadsorption in patients with dilated cardiomyopathy. Felix SB; Staudt A; Friedrich GB Autoimmunity; 2001; 34(3):211-5. PubMed ID: 11908780 [TBL] [Abstract][Full Text] [Related]
40. Effects of antibodies obtained from patients with dilated cardiomyopathy on the function of isolated rat hearts. Staudt Y; Trimpert C; Birkenmeier K; Krieg T; Bemmann T; Beug D; Felix SB; Staudt A Eur J Clin Invest; 2006 Feb; 36(2):85-90. PubMed ID: 16436089 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]